Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    884196 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
Condition: Skin Aging
Interventions: Drug: Botulinum Toxin Type A(Meditoxin®);   Drug: Botulinum Toxin Type A(Botox®)

Indicates status has not been verified in more than two years